Starling Oncology (STLNW) Goodwill & Intangibles (2020 - 2026)

Starling Oncology (STLNW) has reported Goodwill & Intangibles for 7 consecutive years, with $16.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill & Intangibles fell 14.55% year-over-year to $16.8 million; the trailing twelve-month figure through Jun 2026 stood at $16.8 million (down 14.55% YoY), and the FY2025 full-year result was $18.2 million, down 17.22% from the prior year.
• Goodwill & Intangibles retreated to $16.8 million in Q2 2026 per STLNW's latest filing, from $17.5 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $53.9 million in Q2 2022 and bottomed at $16.8 million in Q2 2026.
• Historically, Goodwill & Intangibles has averaged $27.3 million across 5 years, with a median of $23.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles slumped 50.72% in 2023, then advanced 11.86% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $39.4 million in 2022, then tumbled by 36.17% to $25.1 million in 2023, then fell by 12.31% to $22.0 million in 2024, then decreased by 17.22% to $18.2 million in 2025, then dropped by 7.84% to $16.8 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $16.8 million, $17.5 million, and $18.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.